Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperphosphatemia and hypoparathyroidism].

M Kamimura1, T Akizawa

  • 1Center of Blood Purification Therapy, Wakayama Medical University.

Clinical Calcium
|March 19, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long waiting time before tooth extraction may increase delayed wound healing in elderly Japanese.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2018
Same author

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2017
Same author

Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

Acquired Downregulation of Donor-Specific Antibody Production After ABO-Incompatible Kidney Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Diel rhythms of calling behavior and pheromone production of oriental tobacco budworm moth,Helicoverpa assulta (Lepidoptera: Noctuidae).

Journal of chemical ecology·2013
Same author

Establishment of transgenic silkworms expressing GAL4 specifically in the haemocyte oenocytoid cells.

Insect molecular biology·2013
Same journal

[The frontier of adipocyte biology, cold environment induces thermogenic genes via epigenomic switch.]

Clinical calcium·2019
Same journal

[Sequential treatment of osteoporosis with anti-sclerostin.]

Clinical calcium·2019
Same journal

[The sequential therapy of romosozumab followed by denosumab for osteoporosis.]

Clinical calcium·2019
Same journal

[Wnt signaling in myeloma.]

Clinical calcium·2019
Same journal

[Fate decision of hematopoietic stem cells by Wnt signaling.]

Clinical calcium·2019
Same journal

[Control of inflammatory bone destruction by targeting the Wnt signaling pathway.]

Clinical calcium·2019
See all related articles

Hypoparathyroidism treatment differs between patients with normal and impaired renal function. Dialysis patients require strict hyperphosphatemia management, though the exact cause and necessity of treating hypoparathyroidism in this group remain unclear.

Area of Science:

  • Endocrinology
  • Nephrology
  • Mineral Metabolism

Context:

  • Hypoparathyroidism presents distinct challenges in patients with normal renal function versus those undergoing dialysis.
  • In normal renal function, hypocalcemia and hyperphosphatemia stem from reduced parathyroid hormone (PTH) synthesis or function.
  • Dialysis patients experience inevitable hyperphosphatemia due to impaired urinary phosphate excretion.

Purpose:

  • To delineate the differing etiologies and therapeutic strategies for hypoparathyroidism in patients with normal renal function compared to dialysis patients.
  • To highlight the critical need for managing hyperphosphatemia in dialysis patients.
  • To address the uncertainty surrounding the pathogenesis and treatment indications of hypoparathyroidism in dialysis patients.

Summary:

Related Experiment Videos

  • Patients with normal renal function require treatment primarily targeting hypocalcemia.
  • Dialysis patients necessitate significantly higher PTH concentrations (3-6 times normal) to maintain bone metabolism due to hyperphosphatemia.
  • The precise pathogenesis of hypoparathyroidism in dialysis patients and whether it warrants treatment remain subjects of ongoing investigation.

Impact:

  • Clarifies distinct treatment approaches for hypoparathyroidism based on renal function.
  • Emphasizes the importance of strict hyperphosphatemia control in dialysis patients.
  • Identifies critical knowledge gaps regarding hypoparathyroidism in renal impairment, guiding future research and clinical practice.